Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5][13]. Core Insights - In 2024, the company achieved a revenue of 10.435 billion yuan, a year-on-year decrease of 9.09%, and a net profit attributable to shareholders of 1.202 billion yuan, down 23.19% year-on-year. For Q1 2025, revenue was 3.241 billion yuan, up 2.04% year-on-year, with a net profit of 435 million yuan, an increase of 1.35% year-on-year [2][10]. - The company is investing in the Huludao project, which is expected to drive new growth. The ongoing construction projects amount to 1.609 billion yuan, primarily for pesticide raw materials and intermediates [4]. - The forecast for net profit attributable to shareholders for 2025-2027 is 1.254 billion yuan, 1.482 billion yuan, and 1.603 billion yuan, respectively, with corresponding EPS of 3.084 yuan, 3.644 yuan, and 3.942 yuan [5][10]. Financial Summary - In 2024, the company's sales expenses were 232 million yuan, up 0.99% year-on-year; management expenses were 468 million yuan, down 9.60%; financial expenses were -65 million yuan, down 11.35%; and R&D expenses were 358 million yuan, down 14.32% [3]. - For 2025 Q1, the production of raw materials was 29,500 tons, with sales of 28,700 tons at a price of 63,000 yuan/ton, a decrease of 8.83% year-on-year. The production of formulations was 13,000 tons, with sales of 15,400 tons at a price of 56,600 yuan/ton, down 1.57% year-on-year [3]. - The company’s projected revenue growth rates for 2025-2027 are 10.68%, 11.17%, and 5.67%, respectively [10].

Investment Rating - The report maintains a "Buy" rating for the company, anticipating a net profit growth of 44.23 billion, 50.74 billion, and 57.92 billion RMB for the years 2025 to 2027, corresponding to P/E ratios of 15, 13, and 11 respectively [5] Core Insights - The company reported a revenue of 5.353 billion RMB in Q1 2025, a year-on-year increase of 12.34%, while the net profit attributable to the parent company was 762 million RMB, a decrease of 3.25% [2] - The company is experiencing stable orders with short-term profit margins affected by the ramp-up of new factories, but overall performance is in line with expectations [2] - The company has successfully launched new factories in Vietnam, Indonesia, and China to meet the growing demand, with two new shoe factories already operational in Q1 2025 [3] - The gross margin for Q1 2025 was 22.90%, down 5.47 percentage points year-on-year, primarily due to the efficiency ramp-up of new factories [3] - The company is expected to gradually restore its profitability as new factories improve operational efficiency through optimized training mechanisms and the deployment of smart production equipment [3] Summary by Sections Performance Review - In Q1 2025, the company achieved a revenue of 5.353 billion RMB, reflecting a 12.34% year-on-year growth, while the net profit attributable to the parent company was 762 million RMB, down 3.25% [2] Operational Analysis - The company sold 49 million pairs of sports shoes in Q1 2025, marking an 8.24% year-on-year increase, with a slight growth in average selling price (ASP) [3] - The company’s gross margin was impacted by new factory ramp-ups, but the net profit margin was 14.26%, down 2.30 percentage points year-on-year [3] Market and Client Dynamics - The company is less affected by tariffs due to its Southeast Asian factories using a processing model and local sourcing of over 50% of raw materials in Vietnam [4] - The company is expected to benefit from new client orders, particularly from Adidas, as it continues to expand its customer base despite slower growth from major clients like Nike [4] Profit Forecast and Valuation - The company is projected to achieve net profits of 44.23 billion, 50.74 billion, and 57.92 billion RMB from 2025 to 2027, with corresponding P/E ratios of 15, 13, and 11 [5]

Investment Rating - The report maintains a "Buy" rating for the company, with expected earnings per share (EPS) of 0.50, 0.59, and 0.61 for 2025 to 2027, respectively, corresponding to price-to-earnings (P/E) ratios of 12x, 10x, and 10x [4] Core Views - The company reported a revenue of 88 billion yuan for 2024, a decrease of 8.3% year-on-year, while net profit attributable to shareholders increased by 18.9% to 7.75 billion yuan [2] - The first quarter of 2025 saw a revenue of 17.6 billion yuan, down 12.1% year-on-year, with a net profit of 1.07 billion yuan, reflecting a significant decline of 40.8% [2] - The company plans a cash dividend of 0.29 yuan per share for 2024, representing a 50.2% payout ratio, with a current dividend yield of approximately 5.0% [2] Summary by Sections Financial Performance - In 2024, the company achieved an on-grid electricity output of 164.7 billion kWh, up 6.6% year-on-year, primarily due to the commissioning of new power generation units [2] - The cost of fuel and spare parts per kWh decreased by 8.3%, which was greater than the average on-grid electricity price decline of 3.6% [2] Market Conditions - The decline in electricity prices in Q1 2025 was greater than the reduction in costs, leading to pressure on profitability, with a gross margin decrease of 2.3 percentage points to 7.1% [3] - The company expects marginal improvement in profitability as high coal inventory is consumed, potentially narrowing the performance decline in subsequent quarters [3] Capital Expenditure and Cash Flow - 2024 marked the peak construction period for the company's thermal power projects, resulting in a net cash outflow of 8.68 billion yuan from investment activities [4] - The company’s operating cash flow is expected to cover capital expenditures, reducing the debt-to-asset ratio from 45.7% at the end of 2023 to 42.3% in Q1 2025 [4] - The net cash outflow from investment activities in Q1 2025 decreased by 24.2% year-on-year, indicating improved cash flow health [4] Future Projections - The company is projected to achieve net profits of 6.63 billion yuan, 7.91 billion yuan, and 8.14 billion yuan from 2025 to 2027, with corresponding EPS estimates [4] - Revenue forecasts show a decline in 2025, with a projected revenue of 81.78 billion yuan, followed by slight growth in subsequent years [8]

Investment Rating - The report maintains a "Buy" rating for the company, with expected EPS for 2025-2027 at 2.28, 2.48, and 2.71 RMB respectively, corresponding to PE ratios of 10, 9, and 8 times [6]. Core Insights - The company reported a revenue decline of 3.81% year-on-year for 2024, with total revenue of 18.48 billion RMB. The net profit attributable to shareholders decreased by 29.38% to 1.417 billion RMB. However, in Q1 2025, revenue and net profit showed a recovery with increases of 12.9% and 23.5% respectively [2][3]. - The company is experiencing steady growth in exports, with a 11.3% increase in revenue from overseas markets in 2024, while domestic sales faced a decline of 14.4% due to weak real estate performance. However, domestic sales are expected to recover in 2025 [3][5]. - The company's overall profit decline in 2024 was influenced by impairment provisions totaling 213 million RMB for bonds and goodwill impairment of 50 million RMB. The gross margin slightly decreased to 32.72% in 2024 [4]. Summary by Sections Performance Review - In 2024, the company reported revenues of 18.48 billion RMB, a decrease of 3.81% year-on-year, and a net profit of 1.417 billion RMB, down 29.38%. Q4 2024 revenue was 4.68 billion RMB, a decline of 7.8% year-on-year. In Q1 2025, revenues increased to 4.91 billion RMB, with net profit rising to 520 million RMB [2]. Operational Analysis - The company’s export revenue grew by 11.3% in 2024, reaching 8.367 billion RMB, while domestic sales fell by 14.4%. The domestic market is expected to recover in 2025 due to improved order intake and government subsidies [3][5]. Financial Metrics - The company’s gross margin for 2024 was 32.72%, slightly down from the previous year, attributed to a higher proportion of low-margin customized furniture in domestic sales. The expense ratios for sales, management, and R&D increased in 2024 [4]. Retail Transformation - The company is transitioning from a manufacturing and wholesale model to a retail-oriented operation, which is expected to support domestic sales growth. In the export market, the company is focusing on expanding into non-U.S. markets and enhancing its overseas production capacity [5].

业绩简评 4 月 28 日公司发布 24 年报和 25Q1 季报，24 年公司营收/归母净 利 / 扣非净利 分别同比 -3.81%/-29.38%/-26.92% 至 184.8/14.17/13.01 亿元，其中 24Q4 收入同比-7.8%至 46.8 亿元。 25Q1 营收/归母净利/扣非净利分别同比+12.9%/+23.5%/+22.2%至 49.1/5.2/4.6 亿元。分红为每股现金分红 1.38 元。 经营分析 外销持续稳健增长，内销 25Q1 预计恢复增长：分区域看，公司外 销依托海外区域持续拓展叠加海外产能优势，24 年收入同比增长 11.3%至 83.67 亿元。内销方面，2024 年地产整体销售、竣工偏 弱，外部环境令公司业绩承压，公司 24 年内销收入同比-14.4%, 其中 24Q4 随着国补政策刺激，前端接单情况有所改善，而出货节 奏滞后预计使得报表端仍承压。25Q1 内销随着出货节奏加快叠加 25 年国补延续，预计整体已恢复个位数增长，而外销 25Q1 受关税 影响有限，预计仍延续双位数增长态势。 计提减值影响 24 年业绩，收入结构变化致毛利率小幅下降：公司 24 年整体利润 ...

业绩简评 风险提示 宏观经济波动；原材料价格波动；项目进展不及预期。 4 月 28 日，公司发布 25 年一季报，25Q1 公司实现收入 35.6 亿 元，同比+7.9%，归母净利润 2.3 亿元，同比+10.8%。 经营分析 业绩超预期，主要源于毛利率回升。根据公司 25 年一季报，公司 25Q1 毛利率 21.5%，同比+1.6pct，或由海外设备收入确认以及气 体项目爬坡、固定成本摊薄所致。 看好公司空分设备业绩释放。根据公司 24 年年报，公司 2024 年 空分设备毛利率 29.9%，依然维持在非常高的水平，盈利能力稳健。 根据石油和化工采供资讯，2025 年 4 月 8 日，新疆山能化工有限 公司准东五彩湾 80 万吨/年煤制烯烃项目空分技术、工艺包及成 套设备专项招标中标候选人公示，第一中标候选人为公司。据我们 测算，未来五年平均每年新增现代煤化工产能对应的空分设备需 求不少于 187 万 Nm3 /h，即 2018-2024 年平均水平的 2.0 倍，2022 年公司在国内空分设备市占率为 43.2%，居第一。看好公司空分设 备业务受益于国内现代煤化工扩产。 盈利预测、估值与评级 预测 25/ ...

Investment Rating - The report maintains a "Buy" rating for the company, anticipating a significant increase in stock price over the next 6-12 months [5][13]. Core Insights - The company reported a total revenue of 31.8 billion RMB for 2024, a year-on-year increase of 22.4%, and a net profit of 4.06 billion RMB, up 31.4% year-on-year [2]. - In Q1 2025, the company achieved a revenue of 8.4 billion RMB, reflecting a 15.3% year-on-year growth and a 2.9% quarter-on-quarter increase, with a net profit of 1.04 billion RMB, which is a slight increase of 0.47% year-on-year and a 26.8% increase quarter-on-quarter [2]. - The company is experiencing rapid growth in tire production and sales, with a production volume of 74.81 million tires in 2024, up 27.6% year-on-year, and sales of 72.16 million tires, up 29.3% year-on-year [3]. - The company is implementing a global strategy, with production bases in Mexico and Indonesia under construction, which is expected to enhance its global market share and drive revenue growth [4]. Summary by Sections Financial Performance - The company’s revenue is projected to grow from 31.8 billion RMB in 2024 to 36.12 billion RMB in 2025, with a growth rate of 13.57% [9]. - The net profit is expected to increase from 4.06 billion RMB in 2024 to 4.49 billion RMB in 2025, reflecting a growth rate of 10.61% [9]. - The diluted earnings per share are forecasted to rise from 1.236 RMB in 2024 to 1.367 RMB in 2025 [9]. Production and Sales - The company’s tire production and sales are on an upward trajectory, with Q1 2025 sales volume increasing by 16.84% year-on-year [3]. - The average selling price of tires has slightly decreased by 0.4% year-on-year due to changes in product structure [3]. Strategic Initiatives - The company is expanding its production capabilities internationally to mitigate trade barriers and enhance its competitive position in the global market [4]. - The construction of new production bases in Mexico and Indonesia is expected to be completed this year, further solidifying the company's global footprint [4].

Investment Rating - The report maintains a "Buy" rating for the company, anticipating a net profit growth of 44.23 billion, 50.74 billion, and 57.92 billion RMB for the years 2025 to 2027, corresponding to PE ratios of 15, 13, and 11 times respectively [5] Core Views - The company reported a revenue of 5.353 billion RMB in Q1 2025, a year-on-year increase of 12.34%, while the net profit attributable to the parent company was 762 million RMB, a decrease of 3.25% [2] - The company is experiencing stable orders with short-term profit margins affected by the ramp-up of new factories, but overall performance is in line with expectations [2] - The company is benefiting from a strong customer base, particularly with new clients like Adidas, which is expected to drive growth despite challenges in the broader market [4] Summary by Sections Performance Review - In Q1 2025, the company achieved a revenue of 5.353 billion RMB, reflecting a 12.34% year-on-year growth. The net profit attributable to the parent company was 762 million RMB, down 3.25% year-on-year, while the non-recurring net profit was 751 million RMB, also down 3.35% [2] Operational Analysis - The company sold 49 million pairs of sports shoes in Q1 2025, an increase of 8.24% year-on-year, with an increase in average selling price (ASP) contributing to order growth. New customer orders have significantly increased, particularly following the partnership with Adidas that began in Q4 2024 [3] - The gross margin for Q1 2025 was 22.90%, a decrease of 5.47 percentage points year-on-year, primarily due to the efficiency ramp-up of new factories. The company plans to enhance operational efficiency through training and the deployment of smart production equipment [3] Market and Client Dynamics - The company is minimally affected by tariffs due to its Southeast Asia factories operating under a processing model, with over 50% of raw materials sourced locally in Vietnam. The company’s production capacity is concentrated in Vietnam and Cambodia, which mitigates the impact of tariff increases announced by the U.S. [4] - The growth strategy relies heavily on new clients like Adidas and On, with strong order momentum expected to continue. The company’s customer acquisition capabilities are highlighted as a key strength, allowing it to achieve rapid growth even as major clients like Nike experience slower growth [4]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [5]. Core Views - The company's revenue for 2024 is projected to be 28.88 billion RMB, a decrease of 12.8% year-on-year, with a net profit of 6.67 billion RMB, down 33.4% year-on-year. The first quarter of 2025 shows a revenue of 11.07 billion RMB, down 31.9% year-on-year, and a net profit of 3.64 billion RMB, down 39.9% year-on-year, which is below market expectations [2]. - The company experienced a 16.3% decline in liquor sales in 2024, totaling 139,000 tons, while the price per ton increased by 3.9% to 203,000 RMB. The revenue from mid-to-high-end liquor and regular liquor was 24.32 billion RMB and 3.93 billion RMB, respectively, reflecting declines of 14.8% and 0.5% [3]. - The company aims to focus on core products and key markets in 2025, with a commitment to cash dividends of no less than 7 billion RMB, corresponding to a current dividend yield of approximately 6.5% [4]. Summary by Sections Performance Review - In 2024, the company achieved a revenue of 28.88 billion RMB, a decrease of 12.8% year-on-year, and a net profit of 6.67 billion RMB, down 33.4% year-on-year. The first quarter of 2025 reported a revenue of 11.07 billion RMB, down 31.9% year-on-year, and a net profit of 3.64 billion RMB, down 39.9% year-on-year, which was below market expectations [2]. Operational Analysis - The company's liquor sales in 2024 decreased by 16.3% to 139,000 tons, while the price per ton increased by 3.9% to 203,000 RMB. Revenue from mid-to-high-end liquor and regular liquor was 24.32 billion RMB and 3.93 billion RMB, respectively, with declines of 14.8% and 0.5% [3]. Financial Quality - The net profit margin for 2024 decreased by 7.1 percentage points to 23.1%, with a gross margin of 73.2%. The first quarter of 2025 saw a net profit margin of 32.9%, down 4.4 percentage points, indicating pressure on profitability due to increased expenses aimed at maintaining market share [4]. Profit Forecast and Valuation - The report projects a 23% reduction in net profit for 2025 and a 27% reduction for 2026. Expected revenues for 2025, 2026, and 2027 are forecasted to decline by 11.0%, followed by increases of 3.0% and 5.8% in subsequent years [5].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [4]. Core Viewpoints - Despite short-term performance pressure due to channel transformation, the company is expected to benefit from product volume potential under the empowerment of China Resources Sanjiu, with an overall positive operational trend anticipated [4]. - The company reported Q1 2025 revenue of 1.61 billion RMB, a year-on-year decrease of 16.5%, and a net profit attributable to shareholders of 90 million RMB, down 31.1% year-on-year [2]. - The company is focusing on brand development and product volume growth, particularly with its strategic products like "Kunzhong Medicine 1381" and "777 Xuesaitong Soft Capsules" [3]. Summary by Sections Performance Review - In Q1 2025, the company achieved revenue of 1.61 billion RMB, a decrease of 16.5% year-on-year, and a net profit of 90 million RMB, down 31.1% year-on-year [2]. - The decline in performance is attributed to multiple factors, including channel transformation and the impact of national Chinese medicine procurement expansion [2]. Operational Analysis - The company is in the final phase of integration with China Resources Sanjiu, with further breakthroughs in channel transformation expected to enhance terminal coverage and performance in Q2 2025 [2]. - The focus on brand positioning as a "leading national medicine" and the emphasis on terminal coverage and sales are expected to drive healthy growth for core products [3]. Profit Forecast and Valuation - The company’s net profit forecasts for 2025, 2026, and 2027 are 740 million RMB, 893 million RMB, and 1.072 billion RMB, respectively, with year-on-year growth rates of 14%, 21%, and 20% [4]. - The expected earnings per share (EPS) for the same years are 0.98 RMB, 1.18 RMB, and 1.42 RMB, with corresponding price-to-earnings (PE) ratios of 17, 14, and 12 times [4].